Kyjacova, Lenka
Saup, Rafael
Rönsch, Kerstin
Wallbaum, Sabine
Dukowic-Schulze, Stefanie http://orcid.org/0000-0003-2675-1075
Foss, Amelia http://orcid.org/0000-0001-5956-6779
Scherer, Sandra D.
Rothley, Melanie
Neeb, Antje
Grau, Nicole
Thiele, Wilko http://orcid.org/0000-0002-8978-4192
Thaler, Sonja
Cremers, Natascha
Sticht, Carsten
Gretz, Norbert
Garvalov, Boyan K. http://orcid.org/0000-0003-0013-9064
Utikal, Jochen http://orcid.org/0000-0001-5316-0241
Sleeman, Jonathan P. http://orcid.org/0000-0003-1718-7687
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (259332240/RTG2099, 259332240/RTG2099, 259332240 / RTG 2099)
Article History
Received: 13 October 2020
Revised: 1 September 2021
Accepted: 17 September 2021
First Online: 5 October 2021
Competing interests
: Jochen Utikal is on the advisory board or has received honoraria and travel support from Amgen, Bristol Myers Squibb, GSK, LeoPharma, Merck Sharp and Dohme, Novartis, Pierre Fabre, Roche, outside the submitted work. The remaining authors declare no competing interests.